<p>A comparison of recurrence between LC and non-LC group except patients with TNM stage IV.</p
Comparisons of clinical outcome between the severe group and the moderate group.</p
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
<p>The variables found significant after comparison of frequencies between recurrent vs. non-recurre...
Comparison of patient demographics between recurrence and no recurrence group.</p
Comparison of the radiographic parameters between recurrence and no recurrence group.</p
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
<p>Compared with surgical outcomes and complications between LC and non-LC group.</p
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
<p>Comparison of incidence of LNM between matched NACT group and PST group, primary NACT group with ...
<p>Comparison of 3-year recurrence between hepatocellular carcinoma therapy and non-immunotherapy po...
<p>Comparison of incidence and distribution of LNM between the matched NACT and PST group (A-B), cli...
<p>Comparison of 1-year recurrence between hepatocellular carcinomatherapy and non-immunotherapy pos...
BC vs BC2TC for stage I (A); BC vs BC2TC for stage II (B); BC vs BC2TC for stage III (C); BC vs BC2T...
Cross-sectional comparisons between treated patients (Group A) and untreated patients (Group B).</p
<p>Comparisons between patients with readmission and non-readmission at 3 months.</p
Comparisons of clinical outcome between the severe group and the moderate group.</p
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
<p>The variables found significant after comparison of frequencies between recurrent vs. non-recurre...
Comparison of patient demographics between recurrence and no recurrence group.</p
Comparison of the radiographic parameters between recurrence and no recurrence group.</p
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
<p>Compared with surgical outcomes and complications between LC and non-LC group.</p
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
<p>Comparison of incidence of LNM between matched NACT group and PST group, primary NACT group with ...
<p>Comparison of 3-year recurrence between hepatocellular carcinoma therapy and non-immunotherapy po...
<p>Comparison of incidence and distribution of LNM between the matched NACT and PST group (A-B), cli...
<p>Comparison of 1-year recurrence between hepatocellular carcinomatherapy and non-immunotherapy pos...
BC vs BC2TC for stage I (A); BC vs BC2TC for stage II (B); BC vs BC2TC for stage III (C); BC vs BC2T...
Cross-sectional comparisons between treated patients (Group A) and untreated patients (Group B).</p
<p>Comparisons between patients with readmission and non-readmission at 3 months.</p
Comparisons of clinical outcome between the severe group and the moderate group.</p
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
<p>The variables found significant after comparison of frequencies between recurrent vs. non-recurre...
DOI
Add to ORKG